Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 19, 2008. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) rather than a comprehensive financial results announcement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure regarding insider trading activity.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The only reported change is an increase in share ownership by a specific executive.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, risk factors, or contingencies. It details a transaction by Mr. J M Clarke, a PDMR, who acquired 8,580 Ordinary shares on February 8, 2008, at a price of GBP 10.48 each on the London Stock Exchange.
Investor Verification Checklist
- Verify the total shareholding of Mr. J M Clarke following this acquisition.
- Confirm the transaction price of GBP 10.48 against the market price on February 8, 2008.
- Review subsequent filings for any further changes in PDMR interests.